To access the full text documents, please follow this link: http://hdl.handle.net/2445/52919

Metabolic alterations and increased liver mTOR expression precede the development of autoimmune disease in a murine model of lupus erythematosus
Vilà Prats, Laia; Roglans i Ribas, Núria; Baena Muñoz, Miguel; Barroso Fernández, Emma; Alegret i Jordà, Marta; Merlos Roca, Manuel; Laguna Egea, Juan Carlos
Universitat de Barcelona
Although metabolic syndrome (MS) and systemic lupus erythematosus (SLE) are often associated, a common link has not been identified. Using the BWF1 mouse, which develops MS and SLE, we sought a molecular connection to explain the prevalence of these two diseases in the same individuals. We determined SLE- markers (plasma anti-ds-DNA antibodies, splenic regulatory T cells (Tregs) and cytokines, proteinuria and renal histology) and MS-markers (plasma glucose, non-esterified fatty acids, triglycerides, insulin and leptin, liver triglycerides, visceral adipose tissue, liver and adipose tissue expression of 86 insulin signaling-related genes) in 8-, 16-, 24-, and 36-week old BWF1 and control New-Zealand-White female mice. Up to week 16, BWF1 mice showed MS-markers (hyperleptinemia, hyperinsulinemia, fatty liver and visceral adipose tissue) that disappeared at week 36, when plasma anti-dsDNA antibodies, lupus nephritis and a pro-autoimmune cytokine profile were detected. BWF1 mice had hyperleptinemia and high splenic Tregs till week 16, thereby pointing to leptin resistance, as confirmed by the lack of increased liver P-Tyr-STAT-3. Hyperinsulinemia was associated with a down-regulation of insulin related-genes only in adipose tissue, whereas expression of liver mammalian target of rapamicyn (mTOR) was increased. Although leptin resistance presented early in BWF1 mice can slow-down the progression of autoimmunity, our results suggest that sustained insulin stimulation of organs, such as liver and probably kidneys, facilitates the over-expression and activity of mTOR and the development of SLE.
-Lupus eritematós
-Malalties autoimmunitàries
-Malalties del fetge
-Síndrome metabòlica
-Proteïnes quinases
-Citoquines
-Ratolins (Animals de laboratori)
-Lupus erythematosus
-Autoimmune diseases
-Liver diseases
-Metabolic syndrome
-Protein kinases
-Cytokines
-Mice (Laboratory animals)
cc-by (c) Vilà Prats, Laia et al., 2012
http://creativecommons.org/licenses/by/3.0/es
Article
Article - Published version
Public Library of Science (PLoS)
         

Show full item record

Related documents

Other documents of the same author

Rebollo de Grado, Alba; Roglans i Ribas, Núria; Baena Muñoz, Miguel; Padrosa, Anna; Sánchez Peñarroya, Rosa M.; Merlos Roca, Manuel; Alegret i Jordà, Marta; Laguna Egea, Juan Carlos
Rebollo de Grado, Alba; Roglans i Ribas, Núria; Baena Muñoz, Miguel; Sánchez Peñarroya, Rosa M.; Merlos Roca, Manuel; Alegret i Jordà, Marta; Laguna Egea, Juan Carlos
Alegret i Jordà, Marta; Camarasa García, Jordi; Camins Espuny, Antoni; Canudas Teixidó, Anna-Maria; Cañigueral i Folcarà, Salvador; Escubedo Rafa, Elena; Freixa de Reynoso, Blanca; Marin Parés, Esther; Jiménez Guerrero, Andrés; Laguna Egea, Juan Carlos; Merlos Roca, Manuel; Pallàs i Llibería, Mercè, 1964-; Palomer Tarridas, Francesc Xavier; Pérez García, Francisco (Professor); Pubill Sánchez, David; Sánchez Peñarroya, Rosa M.; Rimbau i Barreras, Víctor; Roglans i Ribas, Núria; Vázquez Carrera, Manuel; Vila Casanovas, Roser
Baena Muñoz, Miguel; Sangüesa Puigventós, Gemma; Hutter, Natalia; Sánchez Peñarroya, Rosa M.; Laguna Egea, Juan Carlos; Alegret i Jordà, Marta; Roglans i Ribas, Núria
Rebollo de Grado, Alba; Baena Muñoz, Miguel; Roglans i Ribas, Núria; Alegret i Jordà, Marta; Laguna Egea, Juan Carlos
 

Coordination

 

Supporters